Currently, chemotherapeutic research is using smart and specially engineered multifunctional nanocarriers for targeted nanomedicine for improved and promising cancer treatment. Mesoporous carbon nanomaterials (MCNs) have been widely regarded for this purpose owing to its multifunctional nature. MCNs possess unique combinations of chemical and physical properties along with high surface area, high porosity, biocompatibility and high cellular uptake making them up-and-coming candidates in many areas of biomedical research such as drug delivery, tissue scaffolding, cellular sensors, etc. With a steady increment in the biomedical research centred on MCN as potential nanocarrier systems for chemotherapeutics, the need to determine the optimised conditions to synthesise MCN with the most desirable traits are that much more necessary. One of the critical factors that control the physical, chemical, electrical and mechanical behaviour of MCN is the carbonisation temperature. Carbonisation temperature determines the carbon content, carbon bonding, crystallinity, hydrophobicity, solubility, porosity which in turn influences their effectiveness. Although there have been studies on the characteristic differences in MCNs influenced by carbonisation temperature, however, the impact the carbonisation temperature makes in bio-application of MCN has not been reported so far. So, this PhD aims to study the influence of carbonisation temperature in MCNs and to investigate its behaviour in the biological environment for varied biological applications. In the first part, we prepared mesoporous carbon hollow spheres (MCHS) using resorcinol-formaldehyde polymer and silica hard-template in the one-pot synthesis process. We carbonised the polymer-silica matrix at different carbonisation temperatures (MCHS-T) and studied its changes in physical and chemical properties such as morphology, aqueous distribution, crystallinity, hydrophobicity, carbon content, surface area and porosity. We further investigated the loading capacity and release pattern of the various carbonised samples and their intracellular behaviour. We observed that the delivery of therapeutic biomolecule in cancer cells varied depending on which temperature the nanocarriers were carbonised which led to different cytotoxicity. With this study, we were able to find out the optimised temperature at which mesoporous carbon hollow spheres should be carbonised to achieve the best nanocarrier performance for the delivery of therapeutic protein in cancer therapy. In the second part, we investigated the antioxidant property (free radical scavenging) mediated by the temperature of carbonisation of MCHS-T. We found that MCHS-T is a great antioxidant agent which lowers the ROS levels in cells that are suffering from oxidative stress. We carbonised MCHS-T from temperatures 700-1300˚ C to find the optimised